In January 2024, the FDA updated its guidance on CAR-T therapies, emphasizing the need for enhanced safety and quality measures. This update followed a series of warnings regarding the risk of T cell ...

Biologists have uncovered a quality control timing mechanism tied to cell division. The 'stopwatch' function keeps track of mitosis and acts as a protective measure when the process takes too long, ...

In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory ...

CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

This review article highlights the transformative potential of in vivo CAR T cell therapy in addressing the limitations of traditional CAR T cell production. This innovative approach could ...

One of the fundamental properties for optimizing battery cell performance is battery electrode porosity or void fraction. It is also important for evaluating the quality of cells. Understanding ...

Cell therapy manufacturing is patient-specific and time-sensitive, making regional production capacity increasingly important.

Cellares, the contract drugmaker known for its cell therapy factory-in-a-box, will expand its operations to Europe after ...